6.00
-0.18
(-2.91%)
At close: January 13 at 4:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-12.00
-3,559.00
-7,721.00
-6,577.00
-7,434.00
Investing Cash Flow
-228.00
-126.00
-277.00
-682.00
-96.00
Financing Cash Flow
-269.00
1,742.00
-225.00
16,271.00
9,338.00
End Cash Position
1,053.00
1,502.00
3,445.00
11,668.00
2,656.00
Interest Paid Supplemental Data
67.00
42.00
45.00
34.00
20.00
Capital Expenditure
-228.00
-126.00
-277.00
-682.00
-151.00
Issuance of Capital Stock
78.00
2,245.00
129.00
16,207.00
8,929.00
Issuance of Debt
--
--
--
--
787.00
Repayment of Debt
-597.00
-503.00
-365.00
-209.00
-378.00
Free Cash Flow
-240.00
-3,685.00
-7,998.00
-7,259.00
-7,585.00
12/31/2020 - 6/30/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ICBU iMD Companies, Inc.
0.0025
+4.17%
OCX OncoCyte Corporation
2.0800
-5.88%
ENZ Enzo Biochem, Inc.
0.6643
-2.31%
ISPC iSpecimen Inc.
2.6800
0.00%
TTOO T2 Biosystems, Inc.
0.3200
0.00%
PSNL Personalis, Inc.
5.35
-4.29%
SONA.CN Sona Nanotech Inc.
0.2550
-1.92%
CDNA CareDx, Inc
25.07
+6.09%
VCYT Veracyte, Inc.
42.78
+2.99%
QGEN Qiagen N.V.
46.00
+2.95%